My Locations
Part of the Duke Cancer Institute
About Me
I focus on treating chronic lymphocytic leukemia (CLL). The way the CLL affects patients differs because leukemia can be different in different patients, and how it makes them feel can be very different. And, importantly, their goals of treatment are going to be very different. I want patients to know that I understand that this is a new and different situation for them, and that we’re in this as a partnership for the long haul. I also want them to know that I have compassion for what they are going through. Even though I’ve seen a lot of CLL patients, I’m not in the patient’s shoes, hearing the diagnosis for the first time. I’m passionate about my work, both helping patients and being continually able to learn. A physician has to be passionate about learning because the field is changing and you have to take that information, assimilate it, and be able to relay it to patients.
- Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy 2024
- Member of the Duke Cancer Institute, Duke Cancer Institute 2016
Call for an Appointment
Areas of Expertise
- Lymphoma
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Waldenstrom's Macroglobulinemia
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
In the News
Loading
Loading
Clinical Focus and Research
My research interests focus on chronic lymphocytic leukemia (CLL) and other slow growing lymphomas.
-
Catapult: Ph1a/b CAP-100 (Chronic Lymphocytic Leukemia)IRB# PRO00108139 , NCT# NCT04704323
-
S1925: Phase III Study of Newly Diagnosed Asymptomatic High-Risk Patents with CLL/SLLIRB# PRO00110390 , NCT# NCT04269902
-
BeiGene: Long-term Extension Study of Zanubrutinib in Patients with B-Cell MalignanciesIRB# PRO00112490 , NCT# NCT04170283
-
NurixPhase 1 dose escalation, expansion evaluating NX-5948 (Leukemia and Lymphoma)IRB# PRO00113264 , NCT# NCT05131022
-
Juno (Lymphoma)IRB# PRO00100726 , NCT# NCT03331198
- Shadman, Mazyar, Talha Munir, Tadeusz Robak, Jennifer R. Brown, Brad S. Kahl, Paolo Ghia, Krzysztof Giannopoulos, et al. “Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.” J Clin Oncol 43, no. 7 (March 2025): 780–87. https://doi.org/10.1200/JCO-24-02265.
- Davids, Matthew S., Danielle M. Brander, Yesid Alvarado-Valero, Catherine S. Diefenbach, Daniel N. Egan, Shira N. Dinner, Nathalie Javidi-Sharifi, et al. “A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies.” Blood Adv 9, no. 4 (February 25, 2025): 820–32. https://doi.org/10.1182/bloodadvances.2024014633.
- Kittai, Adam S., Ying Huang, Sarah Miller, John N. Allan, Seema A. Bhat, David A. Bond, Danielle M. Brander, et al. “Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.” Blood Cancer J 15, no. 1 (February 20, 2025): 23. https://doi.org/10.1038/s41408-025-01236-6.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- AbbVie, Inc.
- Alliance for Clinical Trials in Oncology
- ArQule/Merck
- AstraZeneca
- BeiGene
- CLL Society
- Clinical Care Options
- DTRM Biopharma
- Dava Oncology
- Genentech, Inc (Roche Holding)
- Juno/celgene/BMS
- NCCN
- Newave Pharma
- Pharmacyclics
- PlatformQ
- Prime Oncology
- TG Therapeutics
- WebMD/Medscape
- catapult
- nurix